| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |